SYRE NASDAQ
Spyre Therapeutics, Inc.
1W: +8.8%
1M: +7.0%
3M: +5.0%
YTD: +204.7%
1Y: +466.2%
3Y: +711.0%
5Y: -51.4%
$93.19
+3.26 (+3.63%)
Weekly Expected Move ±5.3%
$83
$88
$93
$98
$103
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
📊 Key Metrics
TTM$90M
Revenue
+0.0% YoY
$-179M
Net Income
+13.5% YoY
$-209M
Free Cash Flow
-35.5% YoY
0.0%
Gross Margin
0.0%
Op. Margin
0.0%
Net Margin
💰 Income Flow
How revenue becomes profit💵 Cash Flow
⚠️ Cash Burn Where cash goes🏦 Balance Sheet
Assets = Liabilities + Equity📈 Financial Health
Profitability
ROE-23.0%
ROA-20.9%
ROIC359.8%
Valuation
P/E-47.8
P/B7.2
EV/EBITDA-34.4
Leverage
Debt/Equity0.00
Current Ratio18.53
Interest Cov.0.0x
Quality Scores
Piotroski F3/9
Altman Z62.02
Beneish M0.00